The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | COE 51Talk Online Education Group | Jack Jiajia Huang Chief Executive Officer | MOption exercise Class A Ordinary Share, par value US$0.0001indirect: By Spouse | +18,180 | $0.00 | $0 | 511,800 | 3 d ago |
| Oct 1, 2026 | COE 51Talk Online Education Group | Jack Jiajia Huang Chief Executive Officer | MOption exercise Restricted Share Units (RSUs)derivativeindirect: By Spouse | -18,180 | $0.00 | $0 | 54,540 | 3 d ago |
| Oct 6, 2026 | ADPT Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | MOption exercise Common Stock10b5-1 | +11,881 | $12.14 | $144k | 389,683 | 3 d ago |
| Oct 7, 2026 | ADPT Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | MOption exercise Common Stock10b5-1 | +11,881 | $12.14 | $144k | 389,683 | 3 d ago |
| Oct 8, 2026 | ADPT Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | MOption exercise Common Stock10b5-1 | +11,881 | $12.14 | $144k | 389,683 | 3 d ago |
| Oct 6, 2026 | ADPT Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -11,881 | $0.00 | $0 | 332,253 | 3 d ago |
| Oct 7, 2026 | ADPT Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -11,881 | $0.00 | $0 | 320,372 | 3 d ago |
| Oct 8, 2026 | ADPT Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -11,881 | $0.00 | $0 | 308,491 | 3 d ago |
| Oct 6, 2026 | VNO VORNADO REALTY TRUST | Glen J. Weiss EVP- OFF. LEASING CO HEAD R.E. | MOption exercise AO RUsderivative | -100,000 | $0.00 | $0 | 1,417,295 | 3 d ago |
| Oct 6, 2026 | VNO VORNADO REALTY TRUST | Glen J. Weiss EVP- OFF. LEASING CO HEAD R.E. | MOption exercise Class A Unitsderivative | +50,246 | - | - | 332,999 | 3 d ago |
| Oct 6, 2026 | CRWV CoreWeave, Inc. | Karen Boone director | MOption exercise Class A Common Stock | +1,460 | - | - | 10,240 | 3 d ago |
| Oct 6, 2026 | CRWV CoreWeave, Inc. | Karen Boone director | MOption exercise Restricted Stock Unitsderivative | -1,460 | - | - | 7,320 | 3 d ago |
| Oct 6, 2026 | AMCR Amcor plc | Jean-Marc Galvez See Remarks | MOption exercise Ordinary Shares | +38,155 | $0.00 | $0 | 193,444 | 3 d ago |
| Oct 6, 2026 | AMCR Amcor plc | Jean-Marc Galvez See Remarks | MOption exercise Restricted Stock Unitsderivative | +38,155 | $0.00 | $0 | 0 | 3 d ago |
| Oct 6, 2026 | TT Trane Technologies plc | David S Regnery Chair and CEO | MOption exercise Ordinary Shares10b5-1 | +48,091 | $78.97 | $3.8M | 145,042 | 3 d ago |
| Oct 6, 2026 | TT Trane Technologies plc | David S Regnery Chair and CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -48,091 | $0.00 | $0 | 0 | 3 d ago |
| Oct 6, 2026 | IDYA IDEAYA Biosciences, Inc. | Yujiro S Hata President and CEO | MOption exercise Common Stock10b5-1 | +26,338 | $4.31 | $114k | 717,033 | 3 d ago |
| Oct 6, 2026 | IDYA IDEAYA Biosciences, Inc. | Yujiro S Hata President and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -26,338 | $0.00 | $0 | 23,116 | 3 d ago |
| Oct 6, 2026 | LIF Life360, Inc. | Alex Haro director | MOption exercise Common stock10b5-1 | +50,000 | $2.53 | $127k | 1,060,303 | 3 d ago |
| Oct 6, 2026 | LIF Life360, Inc. | Alex Haro director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 145,565 | 3 d ago |
| Oct 6, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | James R Gibson II See Remarks | MOption exercise Common Stock10b5-1 | +500,000 | $1.18 | $590k | 1,745,663 | 3 d ago |
| Oct 6, 2026 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | James R Gibson II See Remarks | MOption exercise Stock Option (right to buy)derivative10b5-1 | -500,000 | $0.00 | $0 | 1,500,000 | 3 d ago |
| Oct 8, 2026 | EW Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | MOption exercise Common Stock10b5-1 | +619 | $72.68 | $45k | 40,653 | 3 d ago |
| Oct 8, 2026 | EW Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -619 | $0.00 | $0 | 3,095 | 3 d ago |
| Oct 6, 2026 | SKYD Skydance Corp | Makan Delrahim Chief Legal Officer | MOption exercise Class B common stock | +150,000 | $0.00 | $0 | 539,107 | 3 d ago |
| Oct 6, 2026 | SKYD Skydance Corp | Makan Delrahim Chief Legal Officer | MOption exercise Restricted Stock Unitsderivative | -150,000 | $0.00 | $0 | 2,400,000 | 3 d ago |
| Oct 6, 2026 | CRSP CRISPR Therapeutics AG | James R. Kasinger General Counsel and Secretary | MOption exercise Common Shares10b5-1 | +1,990 | $13.62 | $27k | 96,774 | 3 d ago |
| Oct 6, 2026 | CRSP CRISPR Therapeutics AG | James R. Kasinger General Counsel and Secretary | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,990 | $0.00 | $0 | 81,242 | 3 d ago |
| Oct 6, 2026 | RLYB Rallybio Corp | Stephen Uden Chief Executive Officer | MOption exercise Common Stock | +22,456 | $6.08 | $137k | 115,620 | 3 d ago |
| Oct 6, 2026 | RLYB Rallybio Corp | Stephen Uden Chief Executive Officer | MOption exercise Option (Right to Buy)derivative | -22,456 | $0.00 | $0 | 0 | 3 d ago |
| Oct 6, 2026 | DELL Dell Technologies Inc. | Silver Lake Partners IV, L.P. director, owner | MOption exercise Class C Common Stockindirect: Held through Silver Lake Partners IV, L.P. | +70,397 | - | - | 70,397 | 3 d ago |
| Oct 6, 2026 | DELL Dell Technologies Inc. | Silver Lake Partners IV, L.P. director, owner | MOption exercise Class B Common Stockderivativeindirect: Held through Silver Lake Partners IV, L.P. | -70,397 | $0.00 | $0 | 16,313,354 | 3 d ago |
| Oct 6, 2026 | DELL Dell Technologies Inc. | Silver Lake Technology Investors V, L.P. director, owner | MOption exercise Class C Common Stockindirect: Held through Silver Lake Technology Investors V, L.P. | +467 | - | - | 467 | 3 d ago |
| Oct 6, 2026 | DELL Dell Technologies Inc. | Silver Lake Technology Investors V, L.P. director, owner | MOption exercise Class B Common Stockderivativeindirect: Held through Silver Lake Technology Investors V, L.P. | -467 | $0.00 | $0 | 108,237 | 3 d ago |
| Oct 6, 2026 | DELL Dell Technologies Inc. | Sl Spv-2, L.p. director, owner | MOption exercise Class C Common Stockindirect: Held through SL SPV-2, L.P. | +68,576 | - | - | 68,576 | 3 d ago |
| Oct 6, 2026 | DELL Dell Technologies Inc. | Sl Spv-2, L.p. director, owner | MOption exercise Class B Common Stockderivativeindirect: Held through SL SPV-2, L.P. | -68,576 | $0.00 | $0 | 15,891,435 | 3 d ago |
| Oct 6, 2026 | DELL Dell Technologies Inc. | Silver Lake Partners V DE (AIV), L.P. director, owner | MOption exercise Class C Common Stockindirect: Held through Silver Lake Partners V DE (AIV), L.P. | +38,106 | - | - | 38,106 | 3 d ago |
| Oct 6, 2026 | DELL Dell Technologies Inc. | Silver Lake Partners V DE (AIV), L.P. director, owner | MOption exercise Class B Common Stockderivativeindirect: Held through Silver Lake Partners V DE (AIV), L.P. | -38,106 | $0.00 | $0 | 8,830,398 | 3 d ago |
| Oct 6, 2026 | DELL Dell Technologies Inc. | Silver Lake Technology Investors IV, L.P. director, owner | MOption exercise Class C Common Stockindirect: Held through Silver Lake Technology Investors IV, L.P. | +1,036 | - | - | 1,036 | 3 d ago |
| Oct 6, 2026 | DELL Dell Technologies Inc. | Silver Lake Technology Investors IV, L.P. director, owner | MOption exercise Class B Common Stockderivativeindirect: Held through Silver Lake Technology Investors IV, L.P. | -1,036 | $0.00 | $0 | 240,022 | 3 d ago |
| Oct 6, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Helen Torley PRESIDENT AND CEO | MOption exercise Common Stock10b5-1 | +20,000 | $18.41 | $368k | 787,780 | 3 d ago |
| Oct 7, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Helen Torley PRESIDENT AND CEO | MOption exercise Common Stock10b5-1 | +20,000 | $18.41 | $368k | 787,780 | 3 d ago |
| Oct 8, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Helen Torley PRESIDENT AND CEO | MOption exercise Common Stock10b5-1 | +20,000 | $18.41 | $368k | 787,780 | 3 d ago |
| Oct 6, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Helen Torley PRESIDENT AND CEO | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -20,000 | $18.41 | $368k | 61,552 | 3 d ago |
| Oct 7, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Helen Torley PRESIDENT AND CEO | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -20,000 | $18.41 | $368k | 41,552 | 3 d ago |
| Oct 8, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Helen Torley PRESIDENT AND CEO | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -20,000 | $18.41 | $368k | 21,552 | 3 d ago |
| Oct 7, 2026 | UTHR UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | MOption exercise Common Stockindirect: by Trust10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 | 3 d ago |
| Oct 7, 2026 | UTHR UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | MOption exercise Stock Optionderivativeindirect: by Trust10b5-1 | -9,500 | $0.00 | $0 | 280,910 | 3 d ago |
| Oct 6, 2026 | LUXE LuxExperience B.V. | Michael Kliger Chief Executive Officer | MOption exercise Ordinary Share | +119,263 | $8.68 | $1.0M | 119,263 | 3 d ago |
| Oct 7, 2026 | LUXE LuxExperience B.V. | Michael Kliger Chief Executive Officer | MOption exercise Ordinary Share | +65,279 | $8.68 | $567k | 65,279 | 3 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.